Delivery Order SPE2DB22D2211-SPE2DB25FSCGF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on July 22, 2025, with a ceiling value of $3,018.90 and an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with a ceiling value of $2,015.02. This contract is a firm fixed-price delivery order with an ultimate completion date of May 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,137.56 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Telmisartan 20 mg tablets (30-count) under a firm fixed price contract with a ceiling value of $1,836.04. This is an unset-aside, competitively awarded delivery order that will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 9, 2025. The award is issued as a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a competitively procured delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Telmisartan 80 mg tablets (90-count packaging) with a ceiling value of $2,589.93. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The transaction employs firm fixed pricing with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,555.12. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,224.12 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.07 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,942.04 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCGFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan 20 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,031.41. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a child contract under a larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. This delivery order for Telmisartan—an antihypertensive medication used in military and veteran healthcare systems—reflects the company's ongoing role in fulfilling critical pharmaceutical supply needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/5/25 |